Post transplant chronic hepatitis (PTCH): Clinical significance &natural history (original) (raw)
Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation
Claudia Felipe
Brazilian Journal of Medical and Biological Research, 2006
View PDFchevron_right
A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine
George DeVault
Journal of The American Society of Nephrology, 1993
View PDFchevron_right
Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation
Ramon Gomez
Transplant International, 2002
View PDFchevron_right
Evolution of cardiovascular risk after liver transplantation
Michael Porayko
European Journal of Gastroenterology & Hepatology, 1998
View PDFchevron_right
Hyperlipidemia in liver transplant recipients: prevalence and risk factors
Daniela Carrasco
Liver …, 1997
View PDFchevron_right
Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia
Michele Molinari
Liver Transplantation, 2009
View PDFchevron_right
Ischemic Heart Disease after Renal Transplantation in Patients on Cyclosporine in Spain
CARLOS J O A Q U I N MORALES MORALES
Journal of The American Society of Nephrology, 2006
View PDFchevron_right
Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil
G. Imvrios
Transplant International, 2000
View PDFchevron_right
Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease
JM ARIZÓN
The American Journal of Cardiology, 1994
View PDFchevron_right
Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression
Vincent Fradet
Transplantation Proceedings, 2004
View PDFchevron_right
Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation
Luiz Albuquerque
World Journal of Gastroenterology, 2014
View PDFchevron_right
Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation
Mahmoud S Barbir
International Journal of Cardiology, 1991
View PDFchevron_right
Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation
Finn Henriksen
PLOS ONE, 2019
View PDFchevron_right
Cardiovascular Risk Assessment of the Liver Transplant Candidate
Mihai Gheorghiade
Journal of the American …, 2011
View PDFchevron_right
Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients
Neal Azrolan
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
View PDFchevron_right
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus
Domingo Hernández
2003
View PDFchevron_right
Statins Are Safe for the Treatment of Hypercholesterolemia in Patients With Chronic Liver Disease
william sanchez
Gastroenterology, 2008
View PDFchevron_right
Lipid abnormalities in stable liver transplant recipients – effects of cyclosporin, tacrolimus, and steroids
Carlos Guijarro
Transplant International, 1998
View PDFchevron_right
Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
Tadej Battelino
Frontiers in Pediatrics, 2020
View PDFchevron_right
Treatment of hyperlipidemia in cardiac transplant recipients
Roger Blumenthal
American Heart Journal, 2004
View PDFchevron_right
The Impact of Coronary Artery Disease and Statins on Survival after Liver Transplantation
Gurukripa Kowlgi
Liver Transplantation
View PDFchevron_right
Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function
Alkiviadis Kostakis
International Urology and Nephrology, 2008
View PDFchevron_right
Effect of Atorvastatin Therapy and Conversion to Tacrolimus on Hypercholesterolemia and Endothelial Dysfunction After Renal Transplantation
Karl Wissing, Yvon Carpentier
Transplantation, 2006
View PDFchevron_right
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
nadia Hergli
Advances in Therapy
View PDFchevron_right
Liver Transplantation for Homozygous Familial Hypercholesterolemia: Two Case Reports
Mohammad Javad Dehghani
Transplantation Proceedings, 2009
View PDFchevron_right
Hyperlipidemia and cardiovascular diseases in patients with transplanted kidney
Daniela Loncar
Atherosclerosis, 2018
View PDFchevron_right
A long-term study on hyperlipidemia in stable renal transplant recipients
Man-fai Lam
Clinical Transplantation, 2004
View PDFchevron_right
Relation of high levels of high-density lipoprotein cholesterol to coronary artery disease and systemic hypertension
Jaya Singh
American Journal of Cardiology, 2001
View PDFchevron_right